Startseite Expression of SOCS1, SOCS2, and SOCS3 in growth hormone-stimulated skin fibroblasts from children with idiopathic short stature
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Expression of SOCS1, SOCS2, and SOCS3 in growth hormone-stimulated skin fibroblasts from children with idiopathic short stature

  • Paula Ocaranza EMAIL logo , Fernanda Morales , Rossana Román , Germán Iñiguez und Fernando Cassorla
Veröffentlicht/Copyright: 27. Februar 2012
Journal of Pediatric Endocrinology and Metabolism
Aus der Zeitschrift Band 25 Heft 3-4

Abstract

Background/aim: Possible etiologies of idiopathic short stature (ISS) include a range of conditions, some of which may be caused by defects in the modulation of the growth hormone (GH)-signaling pathway. The Janus kinase/signal transducer and activator of transcription pathway is regulated by several mechanisms, including negative feedback regulation by the suppressors of cytokine signaling (SOCS). However, the specific induction of SOCS transcript levels in fibroblasts from ISS patients has not been studied.

Methods: We determined the transcript levels of the SOCS1–3 genes under basal conditions, and in the presence or absence of stimulation with rhGH for 24 h in skin fibroblast cultures obtained from patients with ISS and children with normal height.

Results: Under basal conditions, ISS patients express higher SOCS2–3 transcript levels than control children. After incubation with recombinant human GH (rhGH), the transcript levels of SOCS2 increased significantly in ISS patients compared to controls (0.79±0.06 vs. 0.55±0.07; p=0.03), a pattern which did not achieve statistical significance for SOCS3 transcript levels (0.55±0.08 vs. 0.40±0.07).

Conclusion: The higher baseline transcript levels of the SOCS genes, and the increase observed for SOCS2 after rhGH treatment in ISS patients, suggest that growth retardation in some of these children may be mediated, at least in part, by intracellular overexpression of the SOCS genes.


Corresponding author: Paula Ocaranza, PhD, Institute of Maternal and Child Research, School of Medicine, University of Chile, Avenida Santa Rosa 1234, piso 2, PO Box 226-3, Santiago, 8360160, Chile Phone: +56 (2) 977 0851, Fax: +56 (2) 424 7240

Received: 2011-12-23
Accepted: 2012-1-13
Published Online: 2012-02-27
Published in Print: 2012-04-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Review Articles
  2. Peptide YY in children: a review
  3. Brown adipose tissue: distribution and influencing factors on FDG PET/CT scan
  4. Mini Review
  5. Approach to the management of slipped capital femoral epiphysis and primary hyperparathyroidism
  6. Original Articles
  7. Current normal values for TSH and FT3 in children are too low: evidence from over 11,000 samples
  8. Elevated serum ferritin and soluble transferrin receptor in infants with congenital hypothyroidism
  9. Implications of gastrointestinal hormones in the pathogenesis of obesity in prepubertal children
  10. Oxidative stress in obese children and its relation with insulin resistance
  11. Final height in elite male artistic gymnasts
  12. Expression of SOCS1, SOCS2, and SOCS3 in growth hormone-stimulated skin fibroblasts from children with idiopathic short stature
  13. Evaluation of skeletal maturity score for Korean children and the standard for comparison of bone age and chronological age in normal children
  14. Children and adolescent acceptability of a new device system to administer human growth hormone – a pilot study
  15. The analysis of clinical manifestations and genetic mutations in Chinese boys with primary adrenal insufficiency
  16. Replication of clinical associations with 17-hydroxyprogesterone in preterm newborns
  17. Prevention of bone loss in children receiving long-term glucocorticoids with calcium and alfacalcidol or menatetrenone
  18. Evaluation of serum kisspeptin levels in girls in the diagnosis of central precocious puberty and in the assessment of pubertal suppression
  19. Hypophosphatemia in small for gestational age extremely low birth weight infants receiving parenteral nutrition in the first week after birth
  20. Patient Reports
  21. Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome
  22. Palmoplantar keratoderma with growth hormone deficiency
  23. Propylthiouracil hepatitis: report of a case and extensive review of the literature
  24. Autonomous functioning thyroid nodule successfully treated with radioiodine in a 3 and a half-year-old boy
  25. Hashimoto thyroiditis associated with ataxia telangiectasia
  26. Improved long-term glucose control in neonatal diabetes mellitus after early sulfonylurea allergy
  27. Stroke in a child with Adams-Oliver syndrome and mixed diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome
  28. A novel mutation of the insulin receptor gene in a preterm infant with Donohue syndrome and heart failure
  29. Permanent neonatal diabetes mellitus due to KCNJ11 mutation in a Portuguese family: transition from insulin to oral sulfonylureas
  30. Successful prospective management of neonatal citrullinemia
  31. A Chinese patient with acquired partial lipodystrophy caused by a novel mutation with LMNB2 gene
  32. Warburg Micro syndrome
  33. Inguinal ovary as a rare diagnostic sign of Mayer-Rokitansky-Küster-Hauser syndrome
  34. Letters to the Editor
  35. Endocrine disruptors and fulminant type 1 diabetes: is there a link?
  36. The appropriate use of sensitive tests of hypothalamic-pituitary-adrenal-axis suppression
  37. Meetings
  38. Meetings Calendar
  39. Masthead
  40. Masthead
Heruntergeladen am 31.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2011-0491/html?lang=de
Button zum nach oben scrollen